GMPAS

Project Overview
University
Year
About
Glioma treatment relies on molecular biomarkers that usually require an invasive biopsy and specialist genetic testing, delaying information needed for clinical decisions. GMPAS uses deep learning to analyse standard MRI scans and predict key tumour biomarkers and patient prognosis before surgery. It separates biological patterns from scanner noise, compares new scans with similar historical cases and produces visual maps explaining its predictions. By providing earlier, lower-cost decision support, it could widen access to personalised brain tumour care and help clinicians plan surgery and treatment.
